المؤلفون: Ho Sing Lo (6919322), Kenrie Pui Yan Hui (10653918), Hei-Ming Lai (10653921), Xu He (685343), Khadija Shahed Khan (10653924), Simranjeet Kaur (619694), Junzhe Huang (10653927), Zhongqi Li (5586617), Anthony K. N. Chan (4332478), Hayley Hei-Yin Cheung (10653930), Ka-Chun Ng (10653933), John Chi Wang Ho (10653936), Yu Wai Chen (9198670), Bowen Ma (10653939), Peter Man-Hin Cheung (10653942), Donghyuk Shin (1629241), Kaidao Wang (10653945), Meng-Hsuan Lee (10653948), Barbara Selisko (249846), Cecilia Eydoux (10653951), Jean-Claude Guillemot (479982), Bruno Canard (219785), Kuen-Phon Wu (2036608), Po-Huang Liang (9435), Ivan Dikic (24996), Zhong Zuo (354195), Francis K. L. Chan (10648716), David S. C. Hui (10648713), Vincent C. T. Mok (7343285), Kam-Bo Wong (28485), Chris Ka Pun Mok (7538165), Ho Ko (3227838), Wei Shen Aik (4506667), Michael Chi Wai Chan (10653954), Wai-Lung Ng (3160500)

مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Molecular Biology, Pharmacology, Immunology, Infectious Diseases, Virology, Biological Sciences not elsewhere classified, Information Systems not elsewhere classified, multidisciplinary approach, anti-SARS-CoV -2 mechanism, modulates host, SARS-CoV -2, COVID -19. Simeprevir potently, hepatitis C virus, HCV, RNA-dependent RNA polymerase, syndrome coronavirus 2, protease inhibitor simeprevir, COVID -19, coronavirus disease 2019, repurposable drug, future outbreaks

Relation: https://figshare.com/articles/journal_contribution/Simeprevir_Potently_Suppresses_SARS-CoV_2_Replication_and_Synergizes_with_Remdesivir/14424348

الاتاحة: https://doi.org/10.1021/acscentsci.0c01186.s001